Mankind Pharma Ltd Asset Resilience Ratio

Latest as of March 2026: 5.47%

Mankind Pharma Ltd asset resilience ratio. Mankind Pharma Ltd (MANKIND) has an Asset Resilience Ratio of 5.47% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Mankind Pharma Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs15.37 Billion

≈ $166.25 Million USD Cash + Short-term Investments

Total Assets

Rs280.80 Billion

≈ $3.04 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Mankind Pharma Ltd (2019–2026)

Asset resilience ratio of Mankind Pharma Ltd from 2019 to 2026. This chart shows how Mankind Pharma Ltd's Asset Resilience Ratio has changed over time. Read debt load of Mankind Pharma Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Mankind Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Mankind Pharma Ltd's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs15.37 Billion	5.47%
Total Liquid Assets	Rs15.37 Billion	5.47%

Asset Resilience Insights

Limited Liquidity: Mankind Pharma Ltd maintains only 5.47% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Mankind Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Mankind Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Mankind Pharma Ltd Asset Resilience Ratio by Year (2019–2026)

Mankind Pharma Ltd asset resilience ratio by year from 2019 to 2026. The table below shows the annual Asset Resilience Ratio data for Mankind Pharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	5.47%	Rs15.37 Billion ≈ $166.25 Million	Rs280.80 Billion ≈ $3.04 Billion	-0.62pp
2025-03-31	6.09%	Rs16.91 Billion ≈ $182.86 Million	Rs277.60 Billion ≈ $3.00 Billion	-0.15pp
2024-03-31	6.24%	Rs7.46 Billion ≈ $80.72 Million	Rs119.63 Billion ≈ $1.29 Billion	-6.36pp
2023-03-31	12.60%	Rs12.24 Billion ≈ $132.35 Million	Rs97.15 Billion ≈ $1.05 Billion	+1.92pp
2022-03-31	10.68%	Rs9.77 Billion ≈ $105.63 Million	Rs91.48 Billion ≈ $989.29 Million	-18.15pp
2021-03-31	28.83%	Rs18.37 Billion ≈ $198.70 Million	Rs63.73 Billion ≈ $689.18 Million	+11.91pp
2020-03-31	16.92%	Rs8.58 Billion ≈ $92.82 Million	Rs50.73 Billion ≈ $548.66 Million	+16.32pp
2019-03-31	0.60%	Rs246.21 Million ≈ $2.66 Million	Rs41.12 Billion ≈ $444.74 Million	--

pp = percentage points

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$11.14 Billion

Rs1.03 Trillion INR

Market Cap Rank

#1999 Global

#77 in India

Share Price

Rs2492.80

Change (1 day)

+0.95%

52-Week Range

Rs1927.40 - Rs2617.90

All Time High

Rs2998.40